Maximizing NK Cell Viability & Cytotoxicity Through Novel Expansion Technology
Time: 1:30 pm
day: Day 2 - Track B - PM
Details:
• Leveraging the apexNK™ platform for high purity affordable NK expansion, without the need for sorting or feeder cells
• Highlighting preliminary efficacy of NK cells expanded this way to target lymphomas and solid tumors
• Successfully creating targeted apexNK™ cells utilizing a non-viral ACC™ chemical conjugation technology, specifically designed for blood NK cells
